138 related articles for article (PubMed ID: 3060260)
1. Comparative analysis of different approaches to investigate cell kinetics.
Silvestrini R; Costa A; Veneroni S; Del Bino G; Persici P
Cell Tissue Kinet; 1988 Mar; 21(2):123-31. PubMed ID: 3060260
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas.
Veneroni S; Costa A; Motta R; Giardini R; Rilke F; Silvestrini R
Hematol Oncol; 1988; 6(1):21-8. PubMed ID: 3343026
[TBL] [Abstract][Full Text] [Related]
3. Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.
Witzig TE; Gonchoroff NJ; Greipp PR; Katzmann JA; Stenson MJ; Habermann TM; Colgan JP; Therneau TM; Banks PM
Am J Clin Pathol; 1989 Mar; 91(3):298-301. PubMed ID: 2646907
[TBL] [Abstract][Full Text] [Related]
4. Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.
Costa A; Silvestrini R; Giardini R; Messina-Gabrielli G; Boracchi P; Veneroni S
Br J Cancer; 1992 Oct; 66(4):680-4. PubMed ID: 1419606
[TBL] [Abstract][Full Text] [Related]
5. DNA-synthesizing cells in oral epithelium have a range of cell cycle durations: evidence from double-labelling studies using tritiated thymidine and bromodeoxyuridine.
Hume WJ
Cell Tissue Kinet; 1989 Sep; 22(5):377-82. PubMed ID: 2611853
[TBL] [Abstract][Full Text] [Related]
6. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Silvestrini R; Daidone MG; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
J Clin Oncol; 1990 Aug; 8(8):1321-6. PubMed ID: 2380758
[TBL] [Abstract][Full Text] [Related]
7. Mathematical model analysis of mouse epidermal cell kinetics measured by bivariate DNA/anti-bromodeoxyuridine flow cytometry and continuous [3H]-thymidine labelling.
Aarnaes E; Kirkhus B; Clausen OP
Cell Tissue Kinet; 1990 Sep; 23(5):409-24. PubMed ID: 2245440
[TBL] [Abstract][Full Text] [Related]
8. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
van Oostrum IE; Rozemuller E; Knol RF; Erkens-Schulze S; Rutgers DH
Cell Tissue Kinet; 1990 Nov; 23(6):523-44. PubMed ID: 2276171
[TBL] [Abstract][Full Text] [Related]
10. Changes in cell kinetics induced by primary chemotherapy in breast cancer.
Daidone MG; Silvestrini R; Valentinis B; Ferrari L; Bartoli C
Int J Cancer; 1991 Feb; 47(3):380-3. PubMed ID: 1993544
[TBL] [Abstract][Full Text] [Related]
11. Double labelling with bromodeoxyuridine and [3H]-thymidine of proliferative cells in small intestinal epithelium in steady state and after irradiation.
Chwalinski S; Potten CS; Evans G
Cell Tissue Kinet; 1988 Sep; 21(5):317-29. PubMed ID: 3245954
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.
Costa A; Silvestrini R; Mezzanotte G; Vaglini M; Grignolio E; Clemente C; Cascinelli N
Br J Cancer; 1990 Nov; 62(5):826-9. PubMed ID: 2245175
[TBL] [Abstract][Full Text] [Related]
13. Cell kinetic analysis of human tumor xenografts using anti-bromodeoxyuridine monoclonal antibody.
Kikuyama S; Kubota T; Watanabe M; Isobe Y; Fukutomi T; Ishibiki K; Abe O
Jpn J Surg; 1987 Jan; 17(1):28-32. PubMed ID: 3573442
[TBL] [Abstract][Full Text] [Related]
14. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
15. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
16. Tracer dose and availability time of thymidine and bromodeoxyuridine: application of bromodeoxyuridine in cell kinetic studies.
Böswald M; Harasim S; Maurer-Schultze B
Cell Tissue Kinet; 1990 May; 23(3):169-81. PubMed ID: 2357716
[TBL] [Abstract][Full Text] [Related]
17. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.
Foley J; Ton T; Maronpot R; Butterworth B; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):199-205. PubMed ID: 7912186
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of cell kinetics, histopathology and pathologic stage in non-Hodgkin's lymphomas.
Silvestrini R; Costa A; Giardini R; Boracchi P; Del Bino G; Marubini E; Rilke F
Hematol Oncol; 1989; 7(6):411-22. PubMed ID: 2807179
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity and number of clonal chromosome aberrations in non-Hodgkin's lymphomas.
Brandt L; Kristoffersson U; Olsson H
Scand J Haematol; 1986 Aug; 37(2):106-10. PubMed ID: 3764335
[TBL] [Abstract][Full Text] [Related]
20. Double labelling of cells with tritiated thymidine and bromodeoxyuridine reveals a circadian rhythm-dependent variation in duration of DNA synthesis and S phase flux rates in rodent oral epithelium.
Hume WJ; Thompson J
Cell Tissue Kinet; 1990 Jul; 23(4):313-23. PubMed ID: 2202516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
